Lisanti Capital Growth, LLC Karyopharm Therapeutics Inc. Transaction History

Lisanti Capital Growth, LLC

  • $381 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$14.14 - $19.71 $927,089 - $1.29 Million
-65,565 Closed
0 $0
Q2 2020

Aug 10, 2020
SELL
$16.6 - $25.25 $1.14 Million - $1.73 Million
-68,517 Reduced 51.1%
65,565 $1.24 Million
Q1 2020

May 11, 2020
BUY
$14.38 - $27.72 $105,362 - $203,104
7,327 Added 5.78%
134,082 $2.58 Million
Q4 2019

Feb 13, 2020
BUY
$9.23 - $19.67 $1.17 Million - $2.49 Million
126,755 New
126,755 $2.43 Million

Others Institutions Holding KPTI

# of Institutions
120
Shares Held
72.4M
Call Options Held
476K
Put Options Held
175K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $65.4M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email